Medindia

X

Interest in the Medical Services Dengue Fever Test Kit Continues to Grow

Friday, August 24, 2007 General News J E 4
Advertisement
EDMONTON, Alberta, Aug. 23 Medical ServicesInternational Inc. (Pink Sheets: MSITF) wishes to announce that interest inits VScan Dengue Fever kit continues to increase. Originally, the Company hadprojected that it would sell approximately 250,000 VScan Dengue Fever tests inthe latest fiscal year. Based on independent inquiries and orders fromdistributors the Company has increased its projections for Dengue Fever testkits to 400,000. While not a significant number of kits, it will generatesubstantial cashflow.

The number of countries indicating that Dengue Fever is a becoming aproblem is growing each year. As the accuracy of the VScan Dengue Fever testkit becomes known, the number of test kits required will increase. The Companyis in a position to take advantage of the growth. In most countries, it takes3 to 6 weeks to get test results due to the specialized testing equipmentrequired. The Dengue Fever kit gives results in 20 minutes and costs less than15% of any current test.

About VScan

The VScan rapid test kit is a single use, disposable, accurate, costeffective, easy to use, test for the screening of HIV1&2, Tuberculosis (TB),Hepatitis B&C, Dengue Fever, West Nile, Syphilis. Malaria and Prostate Cancer.The kits cannot be sold in Canada.

Medical Services International Inc. trades in the United States on the NQBPink Sheets under the symbol "MSITF". For further information, please contactRobert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com orhttp://www.minerva-biotech.com.

NOTE: Certain statements in this press release are "forward-lookingstatements" within the meaning of the Private Securities Act of 1995. Suchstatements involve known and unknown risks, uncertainties and other factorsthat may cause results to differ materially. Such risks, uncertainties andother factors include but are not limited to new economic conditions, risk inproduct development, market acceptance of new products and continuing productdemand, level of competition and other factors described in Company reportsand other filings with regulatory bodies

SOURCE Medical Services International Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Nabi Biopharmaceuticals to Present at Upcoming Ind...
S
Health Fitness to Present at the Roth 2007 New Yor...